The FDA s Circulatory System Devices Panel unanimously agreed that Medtronic s Spyral Renal Denervation device was safe, but the panel was split on its efficacy and whether its benefits outweigh the risks.
On August 22-23, 2023, the FDA will conduct an Advisory Committee Meeting to discuss, make recommendations, and vote on renal denervation devices (e.g., devices indicated to reduce.